相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Second haploidentical stem cell transplantation for primary graft failure
Sabrina Giammarco et al.
BONE MARROW TRANSPLANTATION (2021)
Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report
Sajjad Hassan et al.
TRANSFUSION (2021)
The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders
Alberto Cardoso Martins Lima et al.
HLA (2021)
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
Mohamed A. Kharfan-Dabaja et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Yiyu Xie et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation
Shigeo Fuji et al.
BONE MARROW TRANSPLANTATION (2020)
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
Chang Ying-Jun et al.
BONE MARROW TRANSPLANTATION (2020)
Haploidentical transplants for patients with relapse after the first allograft
Samer A. Srour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
Stefania Bramanti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Stefan O. Ciurea et al.
BONE MARROW TRANSPLANTATION (2018)
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies
Hannah Choe et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities
Douglas E. Gladstone et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation
J. Zou et al.
BONE MARROW TRANSPLANTATION (2017)
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
Sarah Morin-Zorman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
Stefan O. Ciurea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
Ying-Jun Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood Transplantation Is Possible Despite Donor-Specific Human Leukoctye Antigen Antibodies
Parastoo B. Dahi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist
Natasha Kekre et al.
BLOOD (2014)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Societe Francophone d'Histocompatibilite et d'Immunogenetique (SFHI) and Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) analysis
Annalisa Ruggeri et al.
HAEMATOLOGICA (2013)
The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children
Marc Ansari et al.
PLOS ONE (2013)
On the role of HLA antibodies in hematopoietic stem cell transplantation
A. Brand et al.
TISSUE ANTIGENS (2013)
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT
S. Yoshihara et al.
BONE MARROW TRANSPLANTATION (2012)
Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation
Corey Cutler et al.
BLOOD (2011)
The impact of anti-HLA antibodies on unrelated cord blood transplantations
Minoko Takanashi et al.
BLOOD (2010)
Human leukocyte antigen antibodies and chronic rejection: From association to causation
Paul I. Terasaki et al.
TRANSPLANTATION (2008)
Allogeneic hematopoietic stem cell transplant using Mismatched/Haploidentical donors
Liang-Piu Koh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation:: Experience of one centre
M Muro et al.
TRANSPLANT IMMUNOLOGY (2005)
分享论文
